Alliance For Clinical Trials In Oncology
Clinical trials sponsored by Alliance For Clinical Trials In Oncology, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Laser therapy offers hope for breast cancer survivors suffering from vaginal dryness Results expected Sep 2026 (estimated)
- Three-Drug chemo may let some rectal cancer patients skip surgery Results expected Sep 2026 (estimated)
- New biobank aims to unlock secrets of Immunotherapy's harsh side effects Results expected Oct 2026 (estimated)
- Gene-Guided drugs aim to shrink brain tumors Results expected Oct 2026 (estimated)
- Immunotherapy combo before surgery shows promise for tough mesothelioma Results expected Dec 2026 (estimated)
-
Could a drug cocktail halt bone Cancer's spread after radiation?
Disease control Stopped earlyThis study tests whether adding a three-drug combination (ixazomib, lenalidomide, and dexamethasone) to zoledronic acid after radiation therapy can prevent solitary plasmacytoma of bone from turning into multiple myeloma. Participants receive either the drug combo plus zoledronic…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a common painkiller stop breast cancer from returning?
Prevention Stopped earlyThis trial tests whether taking aspirin daily can prevent HER2-negative breast cancer from returning in people who have already had surgery, chemotherapy, or radiation. Participants have node-positive or high-risk node-negative breast cancer and are free of recurrence. Half recei…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC